Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Related Citations for PubMed (Select 20153900)

1.

Vitamin E and age-related macular degeneration in a randomized trial of women.

Christen WG, Glynn RJ, Chew EY, Buring JE.

Ophthalmology. 2010 Jun;117(6):1163-8. doi: 10.1016/j.ophtha.2009.10.043. Epub 2010 Feb 13.

2.

Low-dose aspirin and medical record-confirmed age-related macular degeneration in a randomized trial of women.

Christen WG, Glynn RJ, Chew EY, Buring JE.

Ophthalmology. 2009 Dec;116(12):2386-92. doi: 10.1016/j.ophtha.2009.05.031. Epub 2009 Oct 7.

3.

Vitamins E and C and medical record-confirmed age-related macular degeneration in a randomized trial of male physicians.

Christen WG, Glynn RJ, Sesso HD, Kurth T, Macfadyen J, Bubes V, Buring JE, Manson JE, Gaziano JM.

Ophthalmology. 2012 Aug;119(8):1642-9. doi: 10.1016/j.ophtha.2012.01.053. Epub 2012 Apr 13.

4.

Vitamin E and age-related cataract in a randomized trial of women.

Christen WG, Glynn RJ, Chew EY, Buring JE.

Ophthalmology. 2008 May;115(5):822-829.e1. Epub 2007 Dec 11.

PMID:
18067963
5.

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.

Age-Related Eye Disease Study Research Group.

Arch Ophthalmol. 2001 Oct;119(10):1417-36. Erratum in: Arch Ophthalmol. 2008 Sep;126(9):1251.

6.

Age-related cataract in a randomized trial of vitamins E and C in men.

Christen WG, Glynn RJ, Sesso HD, Kurth T, MacFadyen J, Bubes V, Buring JE, Manson JE, Gaziano JM.

Arch Ophthalmol. 2010 Nov;128(11):1397-405. doi: 10.1001/archophthalmol.2010.266.

7.

Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study.

Christen WG, Glynn RJ, Chew EY, Albert CM, Manson JE.

Arch Intern Med. 2009 Feb 23;169(4):335-41. doi: 10.1001/archinternmed.2008.574.

8.

Age-related cataract in men in the selenium and vitamin e cancer prevention trial eye endpoints study: a randomized clinical trial.

Christen WG, Glynn RJ, Gaziano JM, Darke AK, Crowley JJ, Goodman PJ, Lippman SM, Lad TE, Bearden JD, Goodman GE, Minasian LM, Thompson IM Jr, Blanke CD, Klein EA.

JAMA Ophthalmol. 2015 Jan;133(1):17-24. doi: 10.1001/jamaophthalmol.2014.3478.

PMID:
25232809
9.

Dietary ω-3 fatty acid and fish intake and incident age-related macular degeneration in women.

Christen WG, Schaumberg DA, Glynn RJ, Buring JE.

Arch Ophthalmol. 2011 Jul;129(7):921-9. doi: 10.1001/archophthalmol.2011.34. Epub 2011 Mar 14.

10.

Effects of multivitamin supplement on cataract and age-related macular degeneration in a randomized trial of male physicians.

Christen WG, Glynn RJ, Manson JE, MacFadyen J, Bubes V, Schvartz M, Buring JE, Sesso HD, Gaziano JM.

Ophthalmology. 2014 Feb;121(2):525-34. doi: 10.1016/j.ophtha.2013.09.038. Epub 2013 Nov 20.

11.

Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35.

Chew EY, Clemons TE, Agrón E, Sperduto RD, Sangiovanni JP, Kurinij N, Davis MD; Age-Related Eye Disease Study Research Group.

Ophthalmology. 2013 Aug;120(8):1604-11.e4. doi: 10.1016/j.ophtha.2013.01.021. Epub 2013 Apr 10.

12.

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9.

Age-Related Eye Disease Study Research Group.

Arch Ophthalmol. 2001 Oct;119(10):1439-52. Erratum in: Arch Ophthalmol. 2008 Sep;126(9):1251.

13.

Oral docosahexaenoic acid in the prevention of exudative age-related macular degeneration: the Nutritional AMD Treatment 2 study.

Souied EH, Delcourt C, Querques G, Bassols A, Merle B, Zourdani A, Smith T, Benlian P; Nutritional AMD Treatment 2 Study Group.

Ophthalmology. 2013 Aug;120(8):1619-31. doi: 10.1016/j.ophtha.2013.01.005. Epub 2013 Feb 8.

PMID:
23395546
14.

Age-related cataract in a randomized trial of beta-carotene in women.

Christen W, Glynn R, Sperduto R, Chew E, Buring J.

Ophthalmic Epidemiol. 2004 Dec;11(5):401-12.

PMID:
15590586
15.

Vitamin E supplementation and macular degeneration: randomised controlled trial.

Taylor HR, Tikellis G, Robman LD, McCarty CA, McNeil JJ.

BMJ. 2002 Jul 6;325(7354):11.

16.

Secondary outcomes in a clinical trial of carotenoids with coantioxidants versus placebo in early age-related macular degeneration.

Beatty S, Chakravarthy U, Nolan JM, Muldrew KA, Woodside JV, Denny F, Stevenson MR.

Ophthalmology. 2013 Mar;120(3):600-6. doi: 10.1016/j.ophtha.2012.08.040. Epub 2012 Dec 6.

PMID:
23218821
17.

Vitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trial.

Lin J, Cook NR, Albert C, Zaharris E, Gaziano JM, Van Denburgh M, Buring JE, Manson JE.

J Natl Cancer Inst. 2009 Jan 7;101(1):14-23. doi: 10.1093/jnci/djn438. Epub 2008 Dec 30.

18.

Beta carotene supplementation and age-related maculopathy in a randomized trial of US physicians.

Christen WG, Manson JE, Glynn RJ, Gaziano JM, Chew EY, Buring JE, Hennekens CH.

Arch Ophthalmol. 2007 Mar;125(3):333-9.

20.

Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study.

Tan JS, Wang JJ, Flood V, Rochtchina E, Smith W, Mitchell P.

Ophthalmology. 2008 Feb;115(2):334-41. Epub 2007 Jul 30.

PMID:
17664009
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk